Trials / Completed
CompletedNCT02072278
Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects
Interventional, Randomised, Double-blind, Placebo-controlled, Active Comparator, Four-way Crossover Electroencephalography Study Investigating the Effects of Vortioxetine (Lu AA21004) in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To explore a neurophysiological marker (electroencephalography) of cognitive effect of vortioxetine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vortioxetine 10 mg | |
| DRUG | Vortioxetine 20 mg | |
| DRUG | Escitalopram 15 mg | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-11-01
- First posted
- 2014-02-26
- Last updated
- 2015-09-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02072278. Inclusion in this directory is not an endorsement.